Elon Musk's ketamine use can't be probed in OpenAI fraud trial
Published on: March 14, 2026, 9:32 a.m. | Source: Moneycontrol
The trial, scheduled to begin April 28, will revisit the founding years of OpenAI a decade ago, its falling out with Musk and Microsoft Corp.’s subsequent $13 billion investment in the startup.
